Gian-Marco Rinaldi Diaz de la Cruz

Gian-Marco Rinaldi Diaz de la Cruz

Director/Board Member at NLS PHARMACEUTICS LTD.

Net worth: 35 472 $ as of 2024-04-29

51 year
Consumer Services
Health Technology
Miscellaneous

Profile

Mr. Gian-Marco Rinaldi Diaz de la Cruz is an Independent Director at NLS Pharmaceutics Ltd.
and an Equity Partner at Finad AG.
He is on the Board of Directors at NLS Pharmaceutics Ltd.
Mr. Rinaldi Diaz de la Cruz was previously employed as a Managing Director by Clariden Leu AG.
He received his graduate degree from the University of Zurich, a graduate degree from Applied Sciences & Arts Northwestern Switzerland University and a graduate degree from Fachhochschule Nordwestschweiz FHNW.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-05-13 268,725 ( 0.68% ) 35 472 $ 2024-04-29

Gian-Marco Rinaldi Diaz de la Cruz active positions

CompaniesPositionStart
NLS PHARMACEUTICS LTD. Director/Board Member 2021-06-16
Corporate Officer/Principal 2008-12-31
All active positions of Gian-Marco Rinaldi Diaz de la Cruz

Former positions of Gian-Marco Rinaldi Diaz de la Cruz

CompaniesPositionEnd
Clariden Leu AG Corporate Officer/Principal 2008-12-31
See the detail of Gian-Marco Rinaldi Diaz de la Cruz's experience

Training of Gian-Marco Rinaldi Diaz de la Cruz

University of Zurich Graduate Degree
Fachhochschule Nordwestschweiz FHNW Graduate Degree
Applied Sciences & Arts Northwestern Switzerland University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gian-Marco Rinaldi Diaz de la Cruz's experience

Connections

44

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
NLS PHARMACEUTICS LTD.

Health Technology

Private companies2

Miscellaneous

Clariden Leu AG

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Gian-Marco Rinaldi Diaz de la Cruz